Jessica DiLeo & Robert Alesiani | NPA Annual Conference Presentation
Topic: It’s a (Gray) Matter of Fact: Updates in the Management of Neurocognitive Disorder
Session Date and Time: Wednesday, September 20 at 10:00 AM – 11:30 AM EST
Doctors Say These are the Signs of Type 1 Diabetes, Including Fatigue
TRHC’s Robert Alesiani, PharmD, BCGP, shares signs of type 1 diabetes in an article from
Eat This, Not That!
Jean Smart Has Type 1 Diabetes. Here are the Warning Signs
Robert shares more insight on type 1 [...]
Award recognizes outstanding voluntary contributions to the APhA, the profession and society
MOORESTOWN, NJ, March 13, 2018, Tabula Rasa HealthCare, Inc., (“TRHC”) (NASDAQ: TRHC) announced today that Chief Pharmacotherapy Officer Robert L. Alesiani, PharmD, BCGP, has been named the 2018 Hugo H. Schaefer Award winner by the American Pharmacists Association [...]
September 2016
From Pharmacy Today
“Norman Seers” was running errands late one afternoon when he had a painful reminder that he hadn’t taken his medication. He had an urgent need to urinate, but when he found a restroom, he
couldn’t go.
Seers, 77, takes an alpha-1 blocker for an enlarged prostate, [...]
Forbes took a close look at similarities and differences between Ozempic, Wegovy, and Mounjaro. According to Chief Pharmacotherapy Officer Robert Alesiani, Ozempic and Wegovy are both semaglutide-based medications.
Next Avenue spoke with Chief Pharmacotherapy Officer Robert Alesiani for a piece that explores whether medication effectiveness changes over time.
